-
Mitoxantrone (INN, BAN, USAN; also
known as
Mitozantrone in Australia;
trade name Novantrone) is an
anthracenedione antineoplastic agent. Mitoxantrone...
- is an
experimental antineoplastic (anti-cancer) drug, an
analogue of
mitoxantrone with
fewer toxic effects on
cardiac tissue. It acts as a topoisomerase...
-
Uramustine Aclarubicin Daunorubicin Doxorubicin Epirubicin Idarubicin Mitoxantrone Pirarubicin Valrubicin Zorubicin Abraxane Cabazitaxel Docetaxel Larotaxel...
- - an
alkylating antineoplastic agent from the
oxazafosforine group;
Mitoxantrone - a
synthetic anthracycline analogue (anthraquinone) that can intercalate...
-
often daunorubicin (can be
substituted for
doxorubicin or
idarubicin or
mitoxantrone).
There were
attempts to
intensify the "7+3"
regimen in
order to try...
- C2-C14 and C8-C20 base
pairs while maintaining the
structure of i-motif.
Mitoxantrone stabilizes the i-motif and G4 and aids in
their formation under neutral...
- 2011,
mitoxantrone was the
first medication approved for
secondary progressive MS. In this po****tion,
tentative evidence supports mitoxantrone moderately...
-
overall survival (OS) is
markedly enhanced with
cabazitaxel versus mitoxantrone after prior docetaxel treatment.
FIRSTANA (ClinicalTrials.gov identifier:...
- rituximab-containing
chemoimmunotherapy treatment, is
bendamustine with
mitoxantrone and rituximab. In
Germany in 2012 it has
become the
first line treatment...
- ofatumumab, and ublituximab; and immunomodulators:
glatiramer acetate,
mitoxantrone, fingolimod, teriflunomide,
dimethyl fumarate, and
diroximel fumarate...
